Pediatric neuropathology practice in a low- and middle-income country: capacity building through institutional twinning

Ahmed Gilani, Naureen Mushtaq, Muhammad Shakir, Ahmed Altaf, Zainab Siddiq, Eric Bouffet, Uri Tabori, Cynthia Hawkins, Khurram Minhas

Research output: Contribution to journalArticlepeer-review


Background: Accurate and precise diagnosis is central to treating central nervous system (CNS) tumors, yet tissue diagnosis is often a neglected focus in low- and middle-income countries (LMICs). Since 2016, the WHO classification of CNS tumors has increasingly incorporated molecular biomarkers into the diagnosis of CNS tumors. While this shift to precision diagnostics promises a high degree of diagnostic accuracy and prognostic precision, it has also resulted in increasing divergence in diagnostic and management practices between LMICs and high-income countries (HICs). Pathologists and laboratory professionals in LMICs lack the proper training and tools to join the molecular diagnostic revolution. We describe the impact of a 7-year long twinning program between Canada and Pakistan on pathology services. Methods: During the study period, 141 challenging cases of pediatric CNS tumors initially diagnosed at Aga Khan University Hospital (AKUH), Karachi, were sent to the Hospital for Sick Children in Toronto, Canada (SickKids), for a second opinion. Each case received histologic review and often immunohistochemical staining and relevant molecular testing. A monthly multidisciplinary online tumor board (MDTB) was conducted to discuss the results with pathologists from both institutions in attendance. Results: Diagnostic discordance was seen in 30 cases. Expert review provided subclassification for 53 cases most notably for diffuse gliomas and medulloblastoma. Poorly differentiated tumors benefited the most from second review, mainly because of the resolving power of specialized immunohistochemical stains, NanoString, and targeted gene panel next-generation sequencing. Collaboration with expert neuropathologists led to validation of over half a dozen immunostains at AKUH facilitating diagnosis of CNS tumors. Conclusions: LMIC-HIC Institutional twinning provides much-needed training and mentorship to pathologists and can help in infrastructure development by adopting and validating new immunohistochemical stains. Persistent unresolved cases indicate that molecular techniques are indispensable in for diagnosis in a minority of cases. The development of affordable alternative molecular techniques may help with these histologically unresolved cases.

Original languageEnglish
Article number1328374
JournalFrontiers in Oncology
Publication statusPublished - 2024


  • brain tumor
  • diagnosis
  • Low- and lower-middle-income countries
  • next generation (deep) sequencing (NGS)
  • pathology
  • precision diagnostics
  • precision medicine
  • targeted therapy


Dive into the research topics of 'Pediatric neuropathology practice in a low- and middle-income country: capacity building through institutional twinning'. Together they form a unique fingerprint.

Cite this